Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

"LUT014 0.1% gel provides statistically significant benefit over placebo gel for the treatment of acneiform rash associated with cetuximab (Erbitux) or panitumumab (Vectibix) therapy for patients ...

Anti-EGFR therapies, such as cetuximab and panitumumab, are essential for treating many cancers, including colorectal cancer, as per the article. However, they often cause an acneiform rash, reducing ...

“Of those patients with the rash, two thirds had a dose impact on ... colorectal cancer who were receiving cetuximab or panitumumab and had developed grade 2 or noninfected grade 3 acneiform ...

Anti-EGFR therapies, such as cetuximab and panitumumab, are a cornerstone of treatment for many cancers, including colorectal cancer. However, they often cause an acneiform rash that frequently ...

Furthermore, a correlation has been reported for the efficacy of anti-EGFR agents and development of rash. Data indicate ... cetuximab, and panitumumab) are now FDA approved for the treatment ...

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Vectibix (panitumumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets ...

Having a circular rash can spark fears that you’ve picked up ringworm. After all, the fungal infection is notorious for causing a ring-shaped rash. But there are a lot of other circular rashes ...

Chemo rash is one of the most common side effects of cancer treatment. These rashes usually aren’t serious, but they can cause pain, itching, and other uncomfortable symptoms. Chemotherapy ...

The advent of the epidermal growth factor receptor (EGFR) –targeted monoclonal antibodies cetuximab and panitumumab has paved the way to the individualized treatment of metastatic colorectal cancer ...